BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16506946)

  • 1. Transactivating transcriptional activator-mediated drug delivery.
    Gupta B; Torchilin VP
    Expert Opin Drug Deliv; 2006 Mar; 3(2):177-90. PubMed ID: 16506946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
    Futaki S; Nakase I
    Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein transduction: cell penetrating peptides and their therapeutic applications.
    Wagstaff KM; Jans DA
    Curr Med Chem; 2006; 13(12):1371-87. PubMed ID: 16719783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular delivery of nanoparticles with CPPs.
    Sawant R; Torchilin V
    Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF; Filipovska A; Smith RA; Gait MJ; Murphy MP
    Biochem J; 2004 Nov; 383(Pt. 3):457-68. PubMed ID: 15270716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential of cell penetrating peptides for cell drug delivery].
    Poillot C; De Waard M
    Med Sci (Paris); 2011 May; 27(5):527-34. PubMed ID: 21609675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular transduction using cell-penetrating peptides.
    Sawant R; Torchilin V
    Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):816-20. PubMed ID: 17635155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAT-based drug delivery system--new directions in protein delivery for new hopes?
    Rapoport M; Lorberboum-Galski H
    Expert Opin Drug Deliv; 2009 May; 6(5):453-63. PubMed ID: 19413454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.
    Nischan N; Herce HD; Natale F; Bohlke N; Budisa N; Cardoso MC; Hackenberger CP
    Angew Chem Int Ed Engl; 2015 Feb; 54(6):1950-3. PubMed ID: 25521313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study.
    Tseng YL; Liu JJ; Hong RL
    Mol Pharmacol; 2002 Oct; 62(4):864-72. PubMed ID: 12237333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
    Dowaidar M
    Mitochondrion; 2024 May; 78():101906. PubMed ID: 38797356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A; Nervi P; Dürrenberger M; Seelig J
    Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for cytosolic delivery of liposomal macromolecules.
    Fretz MM; Mastrobattista E; Koning GA; Jiskoot W; Storm G
    Int J Pharm; 2005 Jul; 298(2):305-9. PubMed ID: 15941633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.